• Opinion: The monkeypox vaccine underscores the value of U.S. investments in preparedness

    1 month ago - By STAT

    After living through the Covid-19 epidemic, many people around the world reacted to the sudden spread of monkeypox with understandable dismay. But while researchers and public health experts are still learning more about this outbreak , there is one critical distinction between monkeypox and Covid-19: a safe and effective vaccine has been ready and on the shelf from the start, thanks to a long-standing U.S. public-private partnership aimed at preparing for the worst biological threats, whether naturally occurring or deliberate.
    The U.S. government's engagement in the development of medical...
    Read more ...

     

  • CureVac sues BioNTech, claiming Covid-19 vaccine infringes key mRNA patents

    CureVac sues BioNTech, claiming Covid-19 vaccine infringes key mRNA patents

    1 month ago - By MedCity News

    Messenger RNA vaccine biotech CureVac is suing BioNTech, alleging that its rival's Covid-19 vaccine infringes on intellectual property built on more than two decades of research. BioNTech responded that its work is original and the company will defend against the infringement allegations.
    Read more ...